Here’s Why Baron Focused Growth Fund Invested in IDEXX Laboratories (IDXX)
Baron Funds, an investment management firm, released its “Focused Growth Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Posts Tagged ‘NASDAQ:IDXX’
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2025 Earnings Call Transcript
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2025 Earnings Call Transcript May 1, 2025IDEXX Laboratories, Inc. beats earnings expectations.
Should You Sell IDEXX Laboratories (IDXX)?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” fourth-quarter 2024 investor letter.
8 Best Pet Stocks to Buy According to Billionaires
The pet industry is expected to continue growing in the coming years, driven by changing consumer preferences and innovative trends.
12 Best Diagnostics Stocks to Invest In Right Now
According to a report by Mordor Intelligence, the clinical diagnostics market has a size of $88.79 billion as of 2025.
IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory
We came across a bullish thesis on IDEXX Laboratories, Inc. (IDXX) on Substack by Hidden Market Gems. In this article, we will summarize the bulls’ thesis on IDXX.
IDEXX Laboratories (IDXX) Fell Due to Weakening of Clinical Visits by Patients
Baron Funds, an investment management company, released its “Baron Asset Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
Here’s Why IDEXX Laboratories (IDXX) Declined in Q4
Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Jim Cramer On 9 Stocks That Are Rallying Despite Tariff Worries
On Monday, Jim Cramer, the host of Mad Money, told viewers that they should not be too surprised by President Donald Trump's decision to impose steep tariff hikes, a move Trump...
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q4 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the IDEXX Laboratories' Fourth Quarter 2024 Earnings Conference Call. As a reminder, today's conference is being recorded.
Why IDXX Is Soaring Today
Pet healthcare firm Idexx (IDXX) is jumping 10% after delivering better-than-expected fourth-quarter financial results.
Jim Cramer Looked At These 7 Stocks Recently
On Mad Money, Jim Cramer recently delved into the impact of previous President Joe Biden’s policies on the stock market, raising a question that has been on the minds of many...
IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory
We came across a bullish thesis on IDEXX Laboratories, Inc. (IDXX) on Substack by Business Model Mastery. In this article, we will summarize the bulls’ thesis on IDXX.
Jim Cramer Recently Discussed These 7 Stocks
Jim Cramer, host of Mad Money, recently addressed how investors can sometimes lose sight of the broader market perspective.
IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory
We came across a bullish thesis on IDEXX Laboratories, Inc. (IDXX) on Substack by Douglas Ott. In this article, we will summarize the bulls’ thesis on IDXX.
10 Worst Performing Healthcare Stocks in 2024
The healthcare industry remains a vital and resilient sector which is driven by advancements in technology, increasing global demand, and an aging population.
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q3 2024 Earnings Call Transcript
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q3 2024 Earnings Call Transcript October 31, 2024IDEXX Laboratories, Inc. beats earnings expectations.
Here’s Why Aristotle Focus Growth Strategy Sold IDEXX Laboratories (IDXX)
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” third quarter 2024 investor letter.
10 Best Pet Stocks To Invest In According to Analysts
The pet industry is a rapidly growing sector.
IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory
We came across a bullish thesis on IDEXX Laboratories, Inc. (IDXX) on Analyzing Good Businesses’ Substack by YoungHamilton.
10 Best Quality Stocks to Buy According to Analysts
The stock market has seen a notable 20% increase year-to-date, but as it approaches the seasonally volatile months leading up to Election Day, potential volatility is expected...
Here’s Why IDEXX Laboratories (IDXX) Detracted in Q2
Baron Funds, an investment management company, released its “Baron Partners Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q2 2024 Earnings Call Transcript
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q2 2024 Earnings Call Transcript August 6, 2024IDEXX Laboratories, Inc. beats earnings expectations.
Should You Invest in IDEXX Laboratories (IDXX)?
ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” second quarter 2024 investor letter.
50 Largest Companies in Every State in the US
The United States holds the title of the largest economy in the world, according to the IMF in 2024 the United States had a GDP of approximately $28.78 trillion, a GDP per capita...
23 Most Profitable Stocks of the Last 12 Months
In this article, we discuss the 23 most profitable stocks of the last 12 months.
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2024 Earnings Call Transcript
IDEXX Laboratories, Inc. beats earnings expectations. Reported EPS is $2.81, expectations were $2.7.
11 Oversold Growth Stocks to Buy Right Now
In this article, we will take a look at the 11 oversold growth stocks to buy right now.
IDEXX Laboratories (IDXX) Gained 27% on Improved Operating Margins
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” fourth-quarter investor letter.
Strong Fiscal Q3 Earnings Pushed IDEXX Laboratories (IDXX) in Q4
Fred Alger Management, an investment management company, released its “Alger Mid Cap Growth Fund” fourth quarter 2023 investor letter.
IDEXX Laboratories (IDXX) Rebounded After Significant Drawdown From July Highs
Conestoga Capital Advisors, an asset management company, released its “Mid Cap Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
25 Most Valuable Medical Device Companies in the US
In this article, we will be taking a look at the 25 most valuable medical device companies in the US.
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q4 2023 Earnings Call Transcript
IDEXX Laboratories, Inc. beats earnings expectations. Reported EPS is $2.32, expectations were $2.12. IDEXX Laboratories, Inc.
Here’s How IDEXX Laboratories (IDXX) is Delivering Robust Financial Results
Baron Funds, an investment management company, released its “Baron Asset Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
IDEXX Laboratories (IDXX) Surged in 2023
Fundsmith LLP, an investment management company based in London, released its “Fundsmith Equity Fund” 2023 yearly update. A copy of the same can be downloaded here.
Should You Add IDEXX Laboratories (IDXX) to Your Portfolio?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” third-quarter investor letter.
5 Best Pet Stocks to Buy Now
In this article, we will take a look at the 5 best pet stocks to buy now.
IDEXX Laboratories (IDXX) Declined on Weak Clinical Visits Across the Industry
Conestoga Capital Advisors, an asset management company, released its “Mid Cap Strategy” third-quarter 2023 investor letter. A copy of the same can be downloaded here.
IDEXX Laboratories (IDXX) Fell on Investors’ Concerns
Baron Funds, an investment management company, released its “Baron Asset Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here.
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q3 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the IDEXX Laboratories Third Quarter 2023 Earnings Conference Call. As a reminder, today's conference is being recorded.
Top 20 Animal Health Companies in the World
In this article, we will take a detailed look at the Top 20 Animal Health Companies in the World with insights into the revenue generated in 2022.
Here’s Why You Should Hold IDEXX Laboratories (IDXX) for the Long-Term
Baron Funds, an investment management company, released its “Baron Small Cap Fund” second-quarter 2023 investor letter. A copy of the same can be downloaded here.
20 Most Dog Friendly Cities in the US
In this article, we’ll take a look at the 20 Most Dog Friendly Cities in the US.
15 Most Undervalued Large Cap Stocks to Buy According to Wall Street Analysts
In this piece, we will take a look at the 15 most undervalued large cap stocks to buy according to Wall Street analysts.
15 Highest Paying Countries for Veterinarians
In this article, we will look at the 15 highest paying countries for veterinarians.
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q2 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the IDEXX Laboratories Second Quarter 2023 Earnings Conference Call. As a reminder, today's conference is being recorded.
Here’s Why IDEXX Laboratories (IDXX) Rose in Q1
Conestoga Capital Advisors, an asset management company, released its “Mid Cap Strategy” first-quarter 2023 investor letter. A copy of the same can be downloaded here.
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the IDEXX Laboratories First Quarter 2023 Earnings Conference Call. As a reminder, today's conference is being recorded.
Do You Believe in the Long-Term Growth Prospects of IDEXX Laboratories (IDXX)?
Baron Funds, an investment management company, released its “Baron Asset Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.
Strong Q3 Results Pushed IDEXX Laboratories (IDXX) in Q4
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” fourth-quarter investor letter.
